Q2 2013
Released Aug 13, 2013, after the close
10-Q filed Aug 13, 2013, 44 days after period end · 0001144204-13-045172
Q2 2013 · 10-Q
Revenue$575.00K$575.00K +90.4% vs Q2 2012+10.4% vs Q1 2013
Net Income-$1.28M-$1.28M N/M vs Q2 2012N/M vs Q1 2013
EPS Diluted-$0.10-$0.10 N/M vs Q2 2012N/M vs Q1 2013
Gross Profit$349,000+30.7%
Operating Income-$628,000N/M
Operating Cash Flowderived-$1,629,000N/M
Margins · derived
Gross margin60.7%−27.7 pt vs Q2 2012
Operating margin-109.2%+159.7 pt vs Q2 2012
Net margin-222.4%+27.2 pt vs Q2 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $575.00K | $302.00K | $637.00K | — |
| Net Income | -$1.28M | -$754.00K | -$602.00K | -$365.00K |
| EPS Diluted | -$0.10 | -$0.07 | -$0.06 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR